Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On reference values for tumor markers in prostatic carcinoma.

A Lewenhaupt1, P Ekman, P Eneroth

  • 1Department of Urology, Huddinge Hospital, Stockholm, Sweden.

Scandinavian Journal of Urology and Nephrology. Supplementum
|January 1, 1988
PubMed
Summary

Elevated prostate cancer markers like prostatic acid phosphatase and osteocalcin indicate poor prognosis. Adjusting detection levels improves accuracy for identifying at-risk patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Rheumatology international·2021
Same author

Minor effect of loss to follow-up on outcome interpretation in the Swedish spine register.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2019
Same author

Proposal for Another Step on the Path to Total Quality Management.

EJIFCC·2018
Same author

Long-term outcome after spinal fusion for isthmic spondylolisthesis in adults.

The spine journal : official journal of the North American Spine Society·2018
Same author

Age-adjusted D-dimer cut-off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.

Scandinavian journal of rheumatology·2017

Area of Science:

  • Oncology
  • Biochemistry
  • Clinical Diagnostics

Background:

  • Prognostic markers are crucial for managing prostate carcinoma.
  • Current standard cut-off values for tumor markers show limitations in specificity.

Purpose of the Study:

  • To evaluate the prognostic value of serum markers in prostate cancer patients.
  • To determine if adjusted discrimination levels improve prediction of poor prognosis.

Main Methods:

  • Serum levels of prostatic acid phosphatase, neopterin, osteocalcin, tissue polypeptide antigen, and CA-50 were measured in 83 prostate cancer patients.
  • Marker levels were correlated with patient survival after two years.

Main Results:

  • Standard cut-off values demonstrated high sensitivity but low specificity for predicting poor prognosis.

Related Experiment Videos

  • Higher discrimination limits showed a better correlation with prognosis.
  • The degree of marker elevation, rather than mere presence, was more indicative of a poor prognosis.

    • Conclusions:

    • Adjusting discrimination levels for serum tumor markers can enhance specificity with minimal loss of sensitivity.
    • The magnitude of marker elevation is a significant factor in identifying prostate cancer patients with poor prognosis.